MONDAY.COM LTD (MNDY)

IL0011762130 - Common Stock

234.8  +2.95 (+1.27%)

After market: 234.5 -0.3 (-0.13%)

Fundamental Rating

5

Taking everything into account, MNDY scores 5 out of 10 in our fundamental rating. MNDY was compared to 280 industry peers in the Software industry. No worries on liquidiy or solvency for MNDY as it has an excellent financial health rating, but there are worries on the profitability. MNDY is valued quite expensive, but it does show an excellent growth.



3

1. Profitability

1.1 Basic Checks

In the past year MNDY was profitable.
MNDY had a positive operating cash flow in the past year.
In the past 5 years MNDY always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: MNDY reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of MNDY (1.37%) is better than 65.95% of its industry peers.
MNDY has a Return On Equity of 2.23%. This is in the better half of the industry: MNDY outperforms 67.03% of its industry peers.
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROIC N/A
ROA(3y)-9.35%
ROA(5y)-38.64%
ROE(3y)-13.31%
ROE(5y)-243.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MNDY has a Profit Margin of 2.39%. This is in the better half of the industry: MNDY outperforms 66.31% of its industry peers.
MNDY has a better Gross Margin (89.46%) than 96.77% of its industry peers.
MNDY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 89.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.12%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MNDY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNDY has more shares outstanding than it did 1 year ago.
MNDY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MNDY has an Altman-Z score of 12.00. This indicates that MNDY is financially healthy and has little risk of bankruptcy at the moment.
MNDY's Altman-Z score of 12.00 is amongst the best of the industry. MNDY outperforms 84.59% of its industry peers.
MNDY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12
ROIC/WACCN/A
WACC9.36%

2.3 Liquidity

A Current Ratio of 2.67 indicates that MNDY has no problem at all paying its short term obligations.
MNDY has a Current ratio of 2.67. This is in the better half of the industry: MNDY outperforms 72.40% of its industry peers.
MNDY has a Quick Ratio of 2.67. This indicates that MNDY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.67, MNDY is in the better half of the industry, outperforming 72.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67

8

3. Growth

3.1 Past

MNDY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.12%, which is quite impressive.
The Revenue has grown by 33.90% in the past year. This is a very strong growth!
Measured over the past years, MNDY shows a very strong growth in Revenue. The Revenue has been growing by 65.46% on average per year.
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.81%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5YN/A
Sales Q2Q%32.67%

3.2 Future

The Earnings Per Share is expected to grow by 34.85% on average over the next years. This is a very strong growth
MNDY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.06% yearly.
EPS Next Y77.74%
EPS Next 2Y43.15%
EPS Next 3Y37.39%
EPS Next 5Y34.85%
Revenue Next Year33.18%
Revenue Next 2Y29.95%
Revenue Next 3Y28.3%
Revenue Next 5Y27.06%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 76.98, MNDY can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as MNDY.
Compared to an average S&P500 Price/Earnings ratio of 27.54, MNDY is valued quite expensively.
The Price/Forward Earnings ratio is 62.27, which means the current valuation is very expensive for MNDY.
MNDY's Price/Forward Earnings ratio is in line with the industry average.
MNDY is valuated expensively when we compare the Price/Forward Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 76.98
Fwd PE 62.27

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MNDY is valued a bit cheaper than 69.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.09
EV/EBITDA N/A

4.3 Compensation for Growth

MNDY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MNDY's earnings are expected to grow with 37.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y43.15%
EPS Next 3Y37.39%

0

5. Dividend

5.1 Amount

MNDY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONDAY.COM LTD

NASDAQ:MNDY (12/24/2024, 7:26:02 PM)

After market: 234.5 -0.3 (-0.13%)

234.8

+2.95 (+1.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)N/A N/A
Inst Owners80.87%
Inst Owner Change0.4%
Ins Owners16.43%
Ins Owner ChangeN/A
Market Cap11.72B
Analysts81.33
Price Target330.85 (40.91%)
Short Float %6.45%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.74%
Min EPS beat(2)31.58%
Max EPS beat(2)63.89%
EPS beat(4)4
Avg EPS beat(4)59.88%
Min EPS beat(4)31.58%
Max EPS beat(4)96.12%
EPS beat(8)8
Avg EPS beat(8)119.18%
EPS beat(12)12
Avg EPS beat(12)98.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.59%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)1.19%
Revenue beat(4)3
Avg Revenue beat(4)0.64%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)1.19%
Revenue beat(8)7
Avg Revenue beat(8)1.52%
Revenue beat(12)11
Avg Revenue beat(12)2.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.92%
PT rev (3m)9.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.78%
EPS NY rev (1m)12.55%
EPS NY rev (3m)12.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 76.98
Fwd PE 62.27
P/S 12.93
P/FCF 42.09
P/OCF 40.03
P/B 12.07
P/tB 12.07
EV/EBITDA N/A
EPS(TTM)3.05
EY1.3%
EPS(NY)3.77
Fwd EY1.61%
FCF(TTM)5.58
FCFY2.38%
OCF(TTM)5.87
OCFY2.5%
SpS18.16
BVpS19.45
TBVpS19.45
PEG (NY)0.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 89.46%
FCFM 30.73%
ROA(3y)-9.35%
ROA(5y)-38.64%
ROE(3y)-13.31%
ROE(5y)-243.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.12%
GM growth 5YN/A
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 127.47%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 1283.49%
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z 12
F-Score7
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)279.33%
Cap/Depr(5y)286.62%
Cap/Sales(3y)3.19%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.81%
EPS Next Y77.74%
EPS Next 2Y43.15%
EPS Next 3Y37.39%
EPS Next 5Y34.85%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5YN/A
Sales Q2Q%32.67%
Revenue Next Year33.18%
Revenue Next 2Y29.95%
Revenue Next 3Y28.3%
Revenue Next 5Y27.06%
EBIT growth 1Y33.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.97%
EBIT Next 3Y71.75%
EBIT Next 5Y55.44%
FCF growth 1Y2539.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4355.53%
OCF growth 3YN/A
OCF growth 5YN/A